Camelon 125 Dosage/Direction for Use

Usual adult and adolescent dose: Intramuscular or intravenous, 10 to 40 mg (base), repeated as needed. For high-dose (“pulse” therapy): intravenous, 30 mg (base) per kg body weight administered over at least 30 minutes. This dose may be repeated every 4 to 6 hours as needed.
For acute exacerbations of multiple sclerosis: intramuscular or intravenous, 160 mg (base) per day for one week, followed by 64 mg every other day for one month.
For treatment of acute spinal cord injury: intravenous, 30 mg (base) per kg of body weight administered over 15 minutes, followed in 45 minutes by continuous infusion of 5.4 mg per kg body weight per hour, for 23 hours.
For adjunctive treatment in AIDS-associated Pneumocystis carinii: intravenous, 30 mg (base) two times a day on days one through five, 30 mg once on days six through ten, and 15 mg once a day on days eleven trough twenty one.
Usual pediatric dose: Adrenocortical insufficiency: intramuscular, 117 mcg (0.117 mg) (base) per kg of body weight or 3.33 mg (base) per square meter of body surface a day (in three divided doses) every third day; or 39 to 58.5 mcg (0.039 to 0.0585 mg) (base) per kg of body weight or 1.11 to 1.66 mg (base) per square meter of body surface once a day.
For treatment of acute spinal cord injury: intravenous, 30 mg (base) per kg of body weight administered over 15 minutes, followed in 45 minutes by a continuous infusion of 5.4 mg per kg of body weight per hour, for 23 hours.
Other indications: intramuscular, 139 to 835 mcg (0.139 to 0.835 mg) (base) per kg of body weight or 4.16 to 25 mg (base) per square meter of body surface every 12 to 24 hours.
For adjunctive treatment in AIDS-associated Pneumocystis carinii: children 13 years of age and younger dosage has not been established). Children over 13 years of age see usual adult and adolescent dose.
Dosage must be decreased or discontinued gradually when the drug has been administered for more than a few days. If a period of spontaneous remission occurs in chronic condition, treatment should be discontinued. Routine laboratory studies, such as urinalysis, two-hours post-prandial blood sugar, determination of blood pressure and body weight, and a chest x-ray should be made at regular intervals during prolonged therapy.
Method of Administration: CAMELON injection may be administered either by intravenous injection or by intramuscular injection.
Direction for reconstitutions: Add 2 mL of solvent into the vial of dry injection, close the vial and shake until the powder is dissolved.
Direct intravenous can be given at least 1 minute or can be given by intravenous infusion in 5% dextrose, NaCl 0.9% or 5% dextrose in 0.9% NaCl for at least 30 minutes.
The solution is stable physically and chemically for 48 hours at temperature 15°- 30°C.